title: [In vitro oocyte maturation for female fertility preservation].
abstract: Recovering immature oocytes from unstimulated ovaries, followed by in vitro maturation (IVM) was initially proposed to avoid the risks and side effects of exogenous gonadotropin administration. Therefore, during the past decades, IVM was mainly offered to patients with polycystic ovary syndrome at high risk of ovarian hyperstimulation syndrome. However, the development of fertility preservation has recently opened new perspectives in the field of IVM. The present review reports the possible indications of IVM, in the strategy of female fertility preservation.
authors.affiliation: Service de médecine de la reproduction, hôpital Jean-Verdier, Assistance publique-Hôpitaux de Paris, avenue du 14-Juillet, 93140 Bondy, France; UFR de santé, médecine et biologie humaine, université Paris 13, 74, rue Marcel-Cachin, 93017 Bobigny cedex, France.
authors.forename: C
authors.initials: C
authors.lastname: Sonigo
authors.affiliation: Service de médecine de la reproduction, hôpital Jean-Verdier, Assistance publique-Hôpitaux de Paris, avenue du 14-Juillet, 93140 Bondy, France; UFR de santé, médecine et biologie humaine, université Paris 13, 74, rue Marcel-Cachin, 93017 Bobigny cedex, France; Unité Inserm U1133, France. Electronic address: michael.grynberg@jvr.aphp.fr.
authors.forename: M
authors.initials: M
authors.lastname: Grynberg
mesh_terms: D005260:Female; D059247:Fertility Preservation / Q000379:methods*; D006801:Humans; D059471:In Vitro Oocyte Maturation Techniques; D007247:Infertility, Female / Q000209:etiology / Q000628:therapy; D009369:Neoplasms / Q000628:therapy; D054315:Oocyte Retrieval; D011085:Polycystic Ovary Syndrome / Q000150:complications; D011247:Pregnancy; D016896:Treatment Outcome
keywords: Cancer; Fertility preservation; In vitro maturation of oocytes; Maturation ovocytaire in vitro; Préservation de la fertilité; Vitrification